1-3 of 3
Jan Stritesky, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Why Patients with 5q- Syndrome Have Thrombocythemia?

Vit Campr, MD PhD, Jan Stritesky, MD PhD, Ota Fuchs, PhD, Anna Jonasova, MD PhD, Zuzana Zemanova, PhD, Radana Neuwirtova, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5533.
https://doi.org/10.1182/blood.V128.22.5533.5533
Published: 2016
Journal Articles

The Significance Of Fli1 and p53 For The Effective Megakaryopoiesis In 5q- Syndrome and The Effect Of Lenalidomide Treatment

Radana Neuwirtova, MD, PhD, Jan Stritesky, MD, PhD, Ota Fuchs, PhD, Martin Vostry, Arnost Kostecka, Monika Belickova, PhD, Magdalena Siskova, MD, PhD, Kyra Michalova, prof., PhD, Jaroslav Cermak, Ass. Prof., PhD, Anna T Jonasova, MD
Journal: Blood
Blood (2013) 122 (21): 5208.
https://doi.org/10.1182/blood.V122.21.5208.5208
Published: 2013
Journal Articles

Rituximab, Fludarabin and Cyclophosphamide Followed by High Dose Therapy with Autologous Stem Cell Rescue Leads to High Molecular Remission Rate in Chronic Lymphocytic Leukemia patients but Relapses Are Observed.

Marek Trneny, MD, PhD, Jana Salkova, MD, Josef Karban, MD, Jan Cerny, MD, Kyra Michalova, MD, Jan Stritesky, MD, Jiri Schwarz, MD, PhD, Robert Pytlik, MD, Alena Slavickova, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3480.
https://doi.org/10.1182/blood.V104.11.3480.3480
Published: 2004